3-Hydroxyl-3-methylglutaryl-coenzyme a reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemia

Medical Molecular Morphology

Volumn 46, Issue 4, 2013, Pages 239-242

  Sohda, Tetsuro ^a   Iwata, Kaoru ^a   Hirano, Genryu ^a   Sakurai, Kunitoshi ^a   Yokoyama, Keiji ^a   Morihara, Daisuke ^a   Takeyama, Yasuaki ^a   Irie, Makoto ^a   Shakado, Satoshi ^a   Sakisaka, Shotaro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

3 Hydroxyl 3 methylglutaryl coenzyme A (HMG CoA); Cholesterol synthesis; Hepatocellular carcinoma (HCC); Hypercholesterolemia; Immunohistochemistry; Paraneoplastic syndrome

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER MORPHOLOGY; CANCER PATIENT; CANCER SIZE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; UPREGULATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERCHOLESTEROLEMIA; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; UP-REGULATION;

EID: 84891481858     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-013-0042-z     Document Type: Article

References (11)

1. Okuda K (1986) Primary liver cancer. Quadrennial review lecture. Dig Dis Sci 31:133S-146S
2. Luo JC, Hwang SJ, Wu JC, Li CP, Hsiao LT, Lai CR, Chiang JH, Lui WY, Chang FY, Lee SD (1999) Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer 86:799-804
3. Hwang SJ, Lee SD, Chang CF, Wu JC, Tsay SH, Lui WY, Chiang JH, Lo KJ (1992) Hypercholesterolemia in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 7:491-496
4. Hwang SJ, Lee SD, Wu JC, Chang CF, Lu CL, Tsay SH, Lo KJ (1994) Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi (Taipei) 53:262-269
5. Rodwell VW (1972) Cholesterol regulation of hepatic HMG-CoA reductase. Biochem Soc Symp 35:295-301
6. Pedersen TR (1995) Lowering cholesterol with drugs and diet. N Engl J Med 333:1350-1351
7. Mistry P, Miller NE, Laker M, Hazzard WR, Lewis B (1981) Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells. J Clin Invest 67:493-502
8. Knight BL, Patel DD, Soutar AK (1983) The regulation of 3-hydroxy-3-methylglutaryl-CoA reductase activity, cholesterol esterification and the expression of low-density lipoprotein receptors in cultured monocyte-derived macrophages. Biochem J 210:523-532
9. Sohda T, Iwata K, Kitamura Y, Suzuki N, Takeyama Y, Irie M, Anan A, Nakane H, Yoshikane M, Watanabe H, Sakisaka S (2008) Reduced expression of low-density lipoprotein receptor in hepatocellular carcinoma with paraneoplastic hypercholesterolemia. J Gastroenterol Hepatol 23:e153-e156
10. El-Serag HB, Johnson ML, Hachem C, Morgana RO (2009) Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology 136:1601-1608
11. Cao Z, Fan-Minogue H, Bellovin DI, Yevtodiyenko A, Arzeno J, Yang Q, Gambhir SS, Felsher DW (2011) MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Res 71:2286-2297